A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy.

Jang, Won Il

A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy. [electronic resource] - Cancer 01 2020 - 363-372 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1097-0142

10.1002/cncr.32502 doi


Adult
Aged
Aged, 80 and over
Carcinoma, Hepatocellular--mortality
Dose Fractionation, Radiation
Female
Humans
Liver Neoplasms--mortality
Male
Middle Aged
Neoplasm Recurrence, Local--mortality
Progression-Free Survival
Prospective Studies
Radiation Injuries--epidemiology
Radiosurgery--adverse effects
Survival Rate